Description / Application
Favipiravir is a member of the class of pyrazines that is pyrazine substituted by aminocarbonyl, hydroxy and fluoro groups at positions 2, 3 and 6, respectively. It is an anti-viral agent that inhibits RNA-dependent RNA polymerase of several RNA viruses and is approved for the treatment of influenza in Japan. It has a role as an anticoronaviral agent, an EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor and an antiviral drug. It is a primary carboxamide, an organofluorine compound and a hydroxypyrazine.
Identities
| Alternative Name | T-705; 6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide |
|---|---|
| Molecular Formula | C5H4FN3O2 |
| Molecular Weight | 157.1 |
| MFCD | MFCD12032148 |
Safety
| Pictograms |
|
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315;H319;H335 |
| Precautionary Statements | P261;P264;P271;P280;P302+P352;P304+P340;P305+P351+P338;P312;P321;P332+P313;P337+P313;P362;P403+P233;P405;P501 |